Fungal arthritis of the wrist caused byCandida parapsilosisduring infliximab therapy for rheumatoid arthritis

2012 ◽  
Vol 22 (6) ◽  
pp. 903-906 ◽  
Author(s):  
Hideaki Miyamoto ◽  
Toshiki Miura ◽  
Euan Morita ◽  
Yutaka Morizaki ◽  
Kosuke Uehara ◽  
...  
2006 ◽  
Vol 55 (4) ◽  
pp. 343-345 ◽  
Author(s):  
Nikolaos V. Sipsas ◽  
Joseph Papaparaskevas ◽  
Ioanna Stefanou ◽  
Konstantinos Kalatzis ◽  
Panayiotis Vlachoyiannopoulos ◽  
...  

2009 ◽  
Vol 41 (4) ◽  
pp. 252-255 ◽  
Author(s):  
Janine R. Danko ◽  
William R. Gilliland ◽  
R. Scott Miller ◽  
Catherine F. Decker

Rheumatology ◽  
2007 ◽  
Vol 46 (7) ◽  
pp. 1148-1152 ◽  
Author(s):  
C. A. E. Walsh ◽  
P. Minnock ◽  
C. Slattery ◽  
N. Kennedy ◽  
F. Pang ◽  
...  

2009 ◽  
Vol 30 (3) ◽  
pp. 405-408 ◽  
Author(s):  
Takashi Yurube ◽  
Koichiro Takahi ◽  
Hajime Owaki ◽  
Takeshi Fuji ◽  
Masahiro Kurosaka ◽  
...  

2013 ◽  
Vol 12 (2) ◽  
pp. 80-84
Author(s):  
S. P. Oranskyi ◽  
L. N. Eliseeva ◽  
N. A. Samorodskaya ◽  
I. G. Malkhasyan

Aim. To assess the complex dynamics of the main parameters of cardiovascular status and serum markers of endothelial dysfunction (ED) in patients with rheumatoid arthritis (RA), who were treated with infliximab.Material and methods. The main group (MG) included 50 patients with seropositive RA, who received a combination of methotrexate and infliximab. The examination took place at baseline, as well as two, six, and 14 weeks after the treatment started. Comparison groups (CG) included healthy volunteers (n=25) and RA patients treated with methotrexate only (n=110). Serum levels of tumor necrosis factor-α (TNO-α), interleukin-10 (IL-10), tissue plasminogen activator (TPA), and von Willebrand factor (vWf) were measured, using ELISA. Left ventricular (LV) function and microvascular status were assessed with echocardiography and laser Doppler flowmetry (LDF), respectively.Results. The E/A ratio was reduced in all subgroups, and at Week 14 of infliximab therapy, it slightly increased. At baseline, LDF parameters, such as neurogenic arteriole tone and intravascular resistance, were increased. Infliximab therapy was associated with a moderate decline of these parameters. Throughout the study, serum vWf concentration was higher in MG patients than in healthy controls. TPA activity was reduced at baseline (496±173 pg/ml), increasing at Week 14 up to 705±157 pg/ml. Baseline concentrations of TNF-α and UL-10 were substantially elevated (357,1±34 and 453±42 pg/ml, respectively). At Week 6, TNF-α concentration decreased significantly. At Week 14, not only TNF-α level decreased, reaching 94±28 pg/ml, but also the ratio TNF-α/IL-10 decreased (from 0,78±0,5 to 0,4±0,2).Conclusion. In RA patients, infliximab was highly effective for the functional cytokine dysbalance correction, also demonstrating pleiotropic effects, such as correction of microvascular and endothelial dysfunction. 


Sign in / Sign up

Export Citation Format

Share Document